stroke
Conditions
Interventions
experiment group:During the treatment of FES, the VR movements related to the stimulated muscles were observed synchronously.
control group:Watch irrelevant videos (such as scenery, etc.) while receiving FES treatment.
Sponsors
China Rehabilitation Research Center
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: 1. Stroke patients, including cerebral infarction and cerebral hemorrhage, meet the stroke diagnostic criteria established by the fourth National Conference on Cerebrovascular Diseases in 1995; 2. Confirmed as stroke by CT or MRI; 3. Unilateral limb hemiplegia; 4. Brunnstrom grade II~IV; 5. Right-handed, determined by the Edinburgh dominant hand Survey (Edinburgh Handedness Inventory, EHI); 6. Adults, aged 30-70 years old. 7. Subacute stage, the course of the disease is 3 to 6 months; 8. First onset; 9. Mini-Mental State scale (Mini-Mental State Examination, MMSE) score >= 27, able to carry out treatment instructions, without severe cognitive and speech impairment, able to understand passwords and communicate with therapists; 10. Without visual impairment, the international standard visual acuity chart checks binocular vision or corrected vision >= 1.0; 11. The vital signs are stable, the disease is no longer progressing, and can tolerate 30 minutes of treatment per day; 12. Junior high school education or above.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1. Subarachnoid hemorrhage, venous sinus thrombosis, transient ischemic attack, progressive stroke, or reversible cerebral ischemia; 2. Lesions located in bilateral cerebral hemispheres, cerebellum, or brainstem; 3. There are contraindications for FES treatment: skin injuries or skin diseases (such as eczema), acute infections (such as osteomyelitis), vascular diseases (such as thrombosis or phlebitis), metal implants and pacemakers, etc.; 4. Complicated with other major diseases, such as heart, lung, liver, kidney, and other organ diseases or failure; 5. Age < 29 years; 6. Non-first onset; 7. Surgery and other invasive treatment; 8. Other clinical problems that affect the evaluation results, such as poor vision, recent or unhealed fractures, vestibular diseases; 9. Other neurological diseases, such as multiple sclerosis, Parkinson's disease, etc.; 10. There are serious mental and psychological problems.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional Near-Infrared Spectroscopy, fNIRS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Surface electromyography, sEMG;rehabilitation assessment scales; | — |
Countries
China
Contacts
Public ContactCui Yao
Outcome results
None listed